Daniel D. Burgess, Director at Nabriva Therapeutics plc (NBRV), sold 11,341 shares at $0.19 ($2K) on 2022-08-02, disclosed to the SEC on 2022-08-04.
Open-market sale of $2k NBRV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CDTX | BUY | 2015-04-21 | $48K | — | Filing → |
| SNTS | SELL | 2013-06-04 | $171K | — | Filing → |
| SNTS | SELL | 2013-05-02 | $143K | — | Filing → |